Anti-Infectives
The best tips and advice from our vast library of articles, videos, and business tools
Browse Related Topics
Newly Added Articles
- Ayer, Mass., hospital will stay put, expand.
- Fight over Tax Threatens Trenton, N.J., Civic...
- Tyco former chief counsel acquitted of grand...
- Promising Cancer Drug Tarceva A '...
- Job Fears Overshadow Improving Economy in...
- The Business Press, San Bernardino, Calif.,...
- Northwest's On-Time Rate Gets Better.
Article Archives
1-20 (of 4276) related articles
Search Results
|
1-20 (of 4276) related articles
Items per page
| |
|
Prescribing Refrences, Inc.'s (New York) new "MPR Hematology Oncology"...
Prescribing Refrences, Inc.'s (New York) new "MPR Hematology Oncology" edition is a quarterly journal that covers developments with ... (PERIODICAL ARTICLE)
Carbon
HEADNOTE Business absorbed from Adient dissolution helped shop post huge gains CommonHealth's decision to dissolve its professional agency ... (PERIODICAL ARTICLE)
Concerns over Abraxis remain despite plans to undo
merger.
DESPITE a recent spate of positive drug news, Wall Street skeptics are continuing to take a wait-and-see ... (PERIODICAL ARTICLE)
Meeting the consumer's demands.
AM: What products/services does Pfizer Animal Health currently offer? SS: We offer the broadest line of products in ... (PERIODICAL ARTICLE)
Doctor's Choice hands out honors
MERCK'S FOSAMAX threepage professional ads and Daiichi Sankyo's one-page Evoxac ad took top honors at the Doctors' Choice ... (PERIODICAL ARTICLE)
Macrochem acquires option to license Pexiganan, a
novel topical...
MacroChem Corporation (Wellesley Hills, MA) has signed an exclusive option to acquire exclusive worldwide license rights for ... (PERIODICAL ARTICLE)
MacroChem acquires rights to pexiganan for treatment
of diabetic foot...
MacroChem Corporation (Wellesley Hills, MA) exercised the option it acquired in July, 2007 to acquire exclusive worldwide ... (PERIODICAL ARTICLE)
Passage to India
Jubilant Organosys, a pharmaceutical firm based in Noida, India, bought Target Research Associates, a clinical research organization (CRO) ... (PERIODICAL ARTICLE)
The FDA:s antibiotic resistance: if bacteria are
becoming increasingly...
ANTIBIOTIC RESISTANCE OCCURS WHEN bacteria evolve under selection pressure from antibiotic use and become resistant to the medication. (PERIODICAL ARTICLE)
Analyzing the pharmaceutical industry through
quantitative models.
Abstract This paper undertakes two tasks. First, we shall give a summary of the last 50 years of ... (PERIODICAL ARTICLE)
Helix BioMedix files patent application for
antimicrobial hexapeptides.
Helix BioMedix, Inc. (Bothell, WA), a developer of bioactive peptides, announced that the company has filed a patent ... (PERIODICAL ARTICLE)
Pharma site and PBS teach antibiotics
CUBIST Pharmaceuticals has created a new section on its Web site to provide consumers, teachers and grade school ... (PERIODICAL ARTICLE)
Schering-Plough consolidates agencies
SCHERING-PLOUGH in January consolidated marketing and communications for its prescription drugs into Publicis Groupe and Omnicom Group following ... (PERIODICAL ARTICLE)
Novartis AG acquisition of Hexal AG, Eon Labs to
become world's top...
Novartis AG, Basel, Switzerland announced it has signed agreements to acquire 100% of Hexal AG, Holzkirchen, Germany, and ... (PERIODICAL ARTICLE)
Big pharma's problems provide opportunities for
biotech sector.
One company's pain is another's gain. Big pharmaceutical companies have felt pain in 2005. Major drugs are going ... (PERIODICAL ARTICLE)
Pharmaceuticals in China demand to reach 375 billion
Yuan in 2009.
Demand for pharmaceuticals in China is projected to increase 13.6 percent annually to [yen]375 billion in 2010. Western ... (PERIODICAL ARTICLE)
Advancis Pharmaceutical announces issuance of key
patents.
Advancis Pharmaceutical Corporation (Gaithersburg, MD) announced the issuance of United States Patent 6,544,555, entitled "Antibiotic Product, Use and ... (PERIODICAL ARTICLE)
Europe: GlaxoSmithKline selects Bank of New York
GlaxoSmithKline, the result of a merger of Glaxo Wellcome and SmithKline Beecham, Britain's top pharmaceutical companies, selected the ... (PERIODICAL ARTICLE)
Genset licenses entire therapeutic rights for
Chlamydia.
Genset S.A. (Paris, France; 33-1-55-04-59-00) and Ricerca Biosciences, LLC (Concord, OH; 440-357-3090) announced an agreement under which Genset ... (PERIODICAL ARTICLE)
Pharmaceuticals.
A new report from the Tufts Center for the Study of Drug Development details which therapeutic drug classes ... (PERIODICAL ARTICLE) | |
|
1-20 (of 4276) related articles
Items per page
1-20 (of 4276) related articles
|
Newsletter Signup 
- Privacy Policy
We Respect Your Privacy Our Privacy Policy outlines our commitment to your privacy and the importance we place on your trust.
Sponsored Links
Site Map | Contact Us | FAQs | About Us | Media Kit | Reprints | RSS Directory | Sign Up for Free Newsletters | Disclosure Policy
Copyright © 1999 - 2008 AllBusiness.com, Inc. All rights reserved.
No part of this content or the data or information included therein may be reproduced,
republished or redistributed without the prior written consent of AllBusiness.com.
Use of this site is governed by our Copyright and Intellectual Property Policy, Terms of Use Agreement and Privacy Policy.
Get In-Depth Company Information from Hoover's | Buy a D&B Credit Report | What is in Your Company's D&B Credit Report? | Article Archives
Online Business Database | Online Business Information | Email Marketing Lists | Sales and Marketing Solutions | Business Mailing Lists
Online Business Database | Online Business Information | Email Marketing Lists | Sales and Marketing Solutions | Business Mailing Lists
Information and opinions on AllBusiness.com solely represent the thoughts and opinions of the authors and are not endorsed by, or reflect the beliefs of,
AllBusiness.com, its parent company D&B, and its affiliates.
AllBusiness.com, its parent company D&B, and its affiliates.
